CIK 0001724521
- Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473898435
- Phone
- +1 510-694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $84,810
- in 1 filing, $85K under 10b5-1 plans
Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-16 | Tang Carolyn C. General Counsel | Sale | −1,400 | $20.72 | $29K | 25,431 |
| 2022-06-16 | ROSEN TERRY J Chief Executive Officer | Sale | −4,241 | $20.72 | $88K | 232,329 |
| 2022-06-16 | Jarrett Jennifer Chief Operating Officer | Sale | −6,081 | $20.72 | $126K | 125,233 |
| 2022-06-16 | Jaen Juan C. President | Sale | −2,333 | $20.72 | $48K | 212,574 |
| 2022-06-14 | Ribas Antoni Director | Grant or award | +4,100 | 15,150 | ||
| 2022-06-14 | Ribas Antoni Director | Grant or award · Stock Option (Right to Buy) | +16,800 | 16,800 | ||
| 2022-06-14 | PERLMAN ANDREW J Director | Grant or award | +4,100 | 11,125 | ||
| 2022-06-14 | PERLMAN ANDREW J Director | Grant or award · Stock Option (Right to Buy) | +16,800 | 16,800 | ||
| 2022-06-14 | Machado Patrick Director | Grant or award | +4,100 | 10,100 | ||
| 2022-06-14 | Machado Patrick Director | Grant or award · Stock Option (Right to Buy) | +16,800 | 16,800 | ||
| 2022-06-14 | Lambert Nicole Director | Grant or award | +4,100 | 4,100 | ||
| 2022-06-14 | Lambert Nicole Director | Grant or award · Stock Option (Right to Buy) | +16,800 | 16,800 | ||
| 2022-06-14 | Lacey David L. Director | Grant or award | +4,100 | 42,452 | ||
| 2022-06-14 | Lacey David L. Director | Grant or award · Stock Option (Right to Buy) | +16,800 | 16,800 | ||
| 2022-06-14 | KANEKO YASUNORI Director | Grant or award | +4,100 | 4,100 | ||
| 2022-06-14 | KANEKO YASUNORI Director | Grant or award · Stock Option (Right to Buy) | +16,800 | 16,800 | ||
| 2022-06-14 | FALBERG KATHRYN E Director | Grant or award | +4,100 | 90,604 | ||
| 2022-06-14 | FALBERG KATHRYN E Director | Grant or award · Stock Option (Right to Buy) | +16,800 | 16,800 | ||
| 2022-03-16 | Jarrett Jennifer Chief Operating Officer | Sale | −9,617 | $31.62 | $304K | 105,978 |
| 2022-03-08 | Tang Carolyn C. General Counsel | Grant or award | +16,250 | 33,814 |
Page 14 of 20 · 381 trades